MVT

RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

Retrieved on: 
Dienstag, April 16, 2024
Research, Clinical Trials, Health Technology, Biotechnology, Health, Pharmaceutical, General Health, Science, Oncology, MVT, Sale, FDA, Pain, Interventional radiology, Patient, Phase, Risk, Ischemia, Pancreatic cancer, Prevalence, Thrombosis, LAPC, Radiology, MD, Venous thrombosis, Columbia University, Society of Interventional Radiology, Vein, SIR, Associate, TAMP, Coronary thrombosis, Medical imaging

(“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today highlights a presentation of a clinical data abstract at the recent 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting, held March 23-27, 2024 in Salt Lake City, Utah.

Key Points: 
  • (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today highlights a presentation of a clinical data abstract at the recent 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting, held March 23-27, 2024 in Salt Lake City, Utah.
  • Clinical data was presented by David Sperling, MD, Associate Professor of Radiology at Columbia University Irving Medical Center in New York.
  • The data presentation highlighted that of the 25 patients randomized to the TAMP therapy, 6 failed to complete all 8 planned procedures due to thrombosis of the targeted arterial artery.
  • The first interim analysis in the Phase III TIGeR-PaC study was completed in March 2023, with the Data Monitoring Committee recommending a continuation of the study.

Monetate Unveils Digital Merchandising Suite, Designed For Enterprise Teams

Retrieved on: 
Dienstag, Februar 27, 2024
Online Retail, Technology, Professional Services, Electronic Commerce, Marketing, Communications, Digital Marketing, Retail, Data Analytics, Software, Artificial Intelligence, AB, Intelligence, AOV, Market, Catalog, Automation, E-commerce, CVR, MVT, Merchandiser, Online shopping

Monetate, the leading personalization platform that helps build personal and meaningful digital connections between eCommerce brands and their global customers, is proud to announce the launch of Monetate for Merchandisers , a groundbreaking product offering designed to help eCommerce and digital merchandising teams deliver category-defining customer experiences.

Key Points: 
  • Monetate, the leading personalization platform that helps build personal and meaningful digital connections between eCommerce brands and their global customers, is proud to announce the launch of Monetate for Merchandisers , a groundbreaking product offering designed to help eCommerce and digital merchandising teams deliver category-defining customer experiences.
  • Monetate for Merchandisers represents a significant advancement in the realm of eCommerce, marrying the power of artificial intelligence with a comprehensive suite of merchandising tools, buoyed by a robust AB and MVT testing framework.
  • "Monetate for Merchandisers represents a paradigm shift in how companies approach merchandising in a digital age," said Brian Wilson, CEO of Monetate.
  • The announcement of Monetate for Merchandisers has been made official at eTail Palm Springs 2024 and comes on the heels of the launch of Monetate Dynamic Bundles , enabling the automation of ‘Complete the Look’ product sets.

Emerald Geological Services Presents Epworth Project at Vancouver Resource Investment Conference (VRIC), on January 21 & 22, Booth 428

Retrieved on: 
Freitag, Januar 19, 2024
Emerald, MVT, Booth, NWT, Geology, EGS, Conference, SSC

Timmins, Ontario--(Newsfile Corp. - January 19, 2024) - Emerald Geological Services ("EGS" or the "Company") will be presenting at the Vancouver Resource Investment Conference (VRIC), held on January 21 & 22 at Booth 428.

Key Points: 
  • Timmins, Ontario--(Newsfile Corp. - January 19, 2024) - Emerald Geological Services ("EGS" or the "Company") will be presenting at the Vancouver Resource Investment Conference (VRIC), held on January 21 & 22 at Booth 428.
  • EGS will be featuring a selection of High-Grade field samples from the Company's 2021 - 2023 prospecting work on the Epworth Project located in Nunavut.
  • The EGS team will be on hand for details on these new discoveries, property geology and the district scale potential of the property.
  • Mineralization found to date is analogous to sediment-hosted stratiform Cu-(Ag)-(Co) (SSC) deposits (e.g.

Range Energy’s Trailer Electrification Platform Measures 36.3 Percent Fuel Economy Improvements as Tested by MVT Solutions

Retrieved on: 
Freitag, November 17, 2023
Trucking, Other Energy, Logistics, Supply Chain Management, Oil, Gas, Transport, Alternative Energy, Energy, Range, EV, MVT, BEV, Multimedia, GVW, Rail transport

GVW and 60 MPH top speeds across multiple scenarios including stop/go and steady-speed portions.

Key Points: 
  • GVW and 60 MPH top speeds across multiple scenarios including stop/go and steady-speed portions.
  • “Achieving 36.3 percent efficiency improvements proves to the trucking industry how important and overlooked trailers are to enhancing efficiency and lowering emissions for our industry.
  • Whether a fleet wants to reduce fuel usage or increase BEV range, this system provides unique opportunities over a traditional trailer – and by a large amount when considering it achieved 36.3% fuel savings.
  • Our drivers also liked the Range trailer; reporting it pulled easier and felt lighter.

Certain BlackRock Municipal Closed-End Funds Announce Variable Rate Muni Term Preferred Shares Actions

Retrieved on: 
Donnerstag, November 2, 2023
Banking, Professional Services, Finance, MHD, MQT, NYSE, MVT, BlackRock, BFK, MUE, BYM, Fund, Security (finance)

BlackRock Advisors, LLC today announced BlackRock Municipal Income Trust (NYSE: BFK), BlackRock Investment Quality Municipal Trust, Inc. (NYSE: BKN), BlackRock Municipal Income Trust II (NYSE: BLE), BlackRock Municipal Income Quality Trust (NYSE: BYM), BlackRock MuniHoldings Fund , Inc. (NYSE: MHD), BlackRock MuniYield Quality Fund II, Inc. (NYSE: MQT), BlackRock MuniHoldings Quality Fund II, Inc. (NYSE: MUE), BlackRock MuniVest Fund, Inc. (NYSE: MVF), and BlackRock MuniVest Fund II, Inc. (NYSE: MVT) (collectively, the “Funds”) intend to redeem a portion of their outstanding Series W-7 Variable Rate Muni Term Preferred Shares (“VMTP Shares”) on or about November 24, 2023, at a redemption price equal to the liquidation preference of $100,000 per share, together with accumulated and unpaid dividends through the day prior to the redemption date.

Key Points: 
  • BlackRock Advisors, LLC today announced BlackRock Municipal Income Trust (NYSE: BFK), BlackRock Investment Quality Municipal Trust, Inc. (NYSE: BKN), BlackRock Municipal Income Trust II (NYSE: BLE), BlackRock Municipal Income Quality Trust (NYSE: BYM), BlackRock MuniHoldings Fund , Inc. (NYSE: MHD), BlackRock MuniYield Quality Fund II, Inc. (NYSE: MQT), BlackRock MuniHoldings Quality Fund II, Inc. (NYSE: MUE), BlackRock MuniVest Fund, Inc. (NYSE: MVF), and BlackRock MuniVest Fund II, Inc. (NYSE: MVT) (collectively, the “Funds”) intend to redeem a portion of their outstanding Series W-7 Variable Rate Muni Term Preferred Shares (“VMTP Shares”) on or about November 24, 2023, at a redemption price equal to the liquidation preference of $100,000 per share, together with accumulated and unpaid dividends through the day prior to the redemption date.
  • Shareholders are expected to benefit from lower expenses as a result of the redemptions.
  • For more details on each Fund and its VMTP Shares see below:

Ten63 Therapeutics Raises $15.9 Million in Oversubscribed Series A Financing to Drug the Undruggables by Combining the Power of AI and Physics-based Models

Retrieved on: 
Dienstag, Mai 2, 2023
GSK, Duke University, Therapy, Biochemistry, Investment, Engineering, Board Vitals, Vertex, Biotechnology, Cancer, ML, General partnership, DRS, Head, Doctor of Philosophy, Oncogene, Tim Draper, Chemistry, SOSV, Genius, National academy, Protein, Novartis, MacArthur, Patient, Algorithm, Drug discovery, Entrepreneurship, Merck, Human body, SVP, Computer science, MVT, Pfizer, BD, Fine chemical, Pharmaceutical industry, Medical device, Cryptocurrency, Science, Medicine

DURHAM, N.C., May 02, 2023 (GLOBE NEWSWIRE) -- Ten63 Therapeutics, a company combining generative AI and physics-based models to develop first- and best-in-class therapeutics, today announced the closing of an oversubscribed $15.9 million Series A financing led by new investor Hatteras Venture Partners. Morpheus Ventures, SOSV, Draper Associates, Alexandria Venture Investments, the Sigma Group and other new investors also participated in the round.

Key Points: 
  • Morpheus Ventures, SOSV, Draper Associates, Alexandria Venture Investments, the Sigma Group and other new investors also participated in the round.
  • Key to Ten63’s pipeline is the continued development of BEYOND, Ten63’s proprietary computational drug discovery platform.
  • The financing also allows Ten63 to selectively enter key strategic partnerships to further enhance its pipeline.
  • In addition to a groundbreaking computational protein and drug design background, launching Ten63 required a much broader range of expertise.

RenovoRx Announces Initial Results in Pharmacokinetic (PK) Substudy: Data on RenovoGem™ Supports Potential for RenovoTAMP® Therapy Platform to Increase Local Gemcitabine (Chemotherapy) Delivery and Decrease Side Effects of Pancreatic Cancer Treatment

Retrieved on: 
Mittwoch, Januar 18, 2023
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, Toxicity, ASCO, IA, Neoplasm, 2021 Essex County Council election, LAPC, PK, Pancreatic cancer, IV, MVT, SBRT, Amer, Ischemia, Cancer, III, IMRT, Medical imaging, Pharmaceutical industry, MD, Patient

The TIGeR-PaC clinical trial is evaluating intra-arterial (IA) administration of gemcitabine (chemotherapy) using the proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) platform for targeted treatment of Locally Advanced Pancreatic Cancer (LAPC).

Key Points: 
  • The TIGeR-PaC clinical trial is evaluating intra-arterial (IA) administration of gemcitabine (chemotherapy) using the proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMP) platform for targeted treatment of Locally Advanced Pancreatic Cancer (LAPC).
  • The substudy concludes that RenovoTAMP may increase local gemcitabine concentration, which may be beneficial in decreasing gemcitabine-related systemic side effects.
  • “Targeted local delivery of standard dose gemcitabine via the RenovoTAMP therapy platform may be associated with significantly less systemic drug exposure.
  • The poster presentations for the four RenovoRx abstracts to be presented at the ASCO GI Symposium will be available on RenovoRx’s website once available: https://renovorx.com/for-clinicians/ .

DGAP-News: CORRECTING and REPLACING Volatus Aerospace Corp. Announces Record First Quarter 2022 Sales

Retrieved on: 
Donnerstag, Mai 26, 2022
Knowledge, Company, Aviation, Corporation, Non-governmental organization, Kate, UAS, News, Investment, TSX Venture Exchange, Mission statement, SEDAR, Solution, European, MVT, Decision-making, COVID-19, Marketing, Circular, United Kingdom, Intelligence, Industry, Awareness, Program, Eastern Canada, Technology, Lidar, Acquisition, Growth, Phrase, CEO, Video game, Risk management, ISR, Plateros volatus

Announces Record First Quarter 2022 Sales

Key Points: 
  • Announces Record First Quarter 2022 Sales
    The issuer is solely responsible for the content of this announcement.
  • Announces Record First Quarter 2022 Sales" sted "Volatus Aerospace Corp.
  • Announces Record First Quarter Annual Sales"
    Volatus Aerospace Corp. (TSXV: VOL) (OTCQB: VLTTF) ("Volatus" or "the Company"), is pleased to announce record sales for the first quarter of 2022.
  • Revenue for Q1 2022 was $4,807,829, an increase of 64% over the previous quarter and a sixteen-fold increase over the year-on-year quarter of 2021.

DGAP-News: Volatus Aerospace Corp. Announces Record First Quarter Annual Sales

Retrieved on: 
Donnerstag, Mai 26, 2022
Knowledge, Company, Aviation, Corporation, Non-governmental organization, Kate, UAS, News, Investment, TSX Venture Exchange, Mission statement, SEDAR, Solution, European, MVT, Decision-making, COVID-19, Circular, Marketing, United Kingdom, Intelligence, Industry, Awareness, Program, Eastern Canada, Technology, Lidar, Acquisition, Growth, Phrase, CEO, Video game, Risk management, ISR, Plateros volatus

Volatus Aerospace Corp. (TSXV: VOL) (OTCQB: VLTTF) ("Volatus" or "the Company"), is pleased to announce record sales for the first quarter of 2022.

Key Points: 
  • Volatus Aerospace Corp. (TSXV: VOL) (OTCQB: VLTTF) ("Volatus" or "the Company"), is pleased to announce record sales for the first quarter of 2022.
  • Revenue for Q1 2022 was $4,807,829, an increase of 64% over the previous quarter and a sixteen-fold increase over the year-on-year quarter of 2021.
  • Volatus recorded a comprehensive loss of $1,774,397 compared to a comprehensive loss of $1,328,628 in the previous quarter.
  • Through its subsidiary Volatus Aviation, Volatus carries on the business of aircraft management, charter sales, and cargo services using piloted, remotely piloted, and autonomous aircraft.

DGAP-News: Volatus Aerospace Closes Acquisition of MVT Geo-Solutions Inc., a Quebec-based Geomatics Service Company

Retrieved on: 
Samstag, März 5, 2022
Phrase, TSX Venture Exchange, Family, Corporation, Industry, MVT, News, Knowledge, Growth, COVID-19, Acquisition, CEO, Circular, Aviation, Risk, CAD, Cryptocurrency, Risk management, Plateros volatus

Volatus Aerospace Closes Acquisition of MVT Geo-Solutions Inc., a Quebec-based Geomatics Service Company

Key Points: 
  • Volatus Aerospace Closes Acquisition of MVT Geo-Solutions Inc., a Quebec-based Geomatics Service Company
    The issuer is solely responsible for the content of this announcement.
  • Volatus Aerospace Corp. (TSXV: VOL) ('Volatus') is pleased to announce that it has closed its acquisition of MVT Geo-Solutions Inc. ('MVT'), a Quebec, Canada-based leader in geomatics innovations.
  • "With the successful closure of this acquisition, Volatus expands our footprint in Quebec, which is one of the largest markets in Canada.
  • We also increase our expertise in geomatics and our access to national and provincial large-scale clients," stated Glen Lynch, CEO of Volatus.